The Hershey Company (HSY) Stock Forecast
Data as of May 2, 2026Consumer Defensive · Current price $182.63 (-1.68%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 25, 2026 | Michael Lavery | Piper Sandler | $249.00 | +36.3% |
| Feb 6, 2026 | Brian Holland | D.A. Davidson | $243.00 | +33.1% |
| Feb 6, 2026 | Alexia Howard | Bernstein | $250.00 | +36.9% |
| Feb 6, 2026 | David Palmer | Evercore ISI | $250.00 | +36.9% |
| Feb 6, 2026 | Andrew Lazar | Barclays | $240.00 | +31.4% |
| Jan 28, 2026 | Megan Alexander Clapp | Morgan Stanley | $214.00 | +17.2% |
| Jan 26, 2026 | Alexia Howard | Bernstein | $84.00 | -54.0% |
| Jan 5, 2026 | Chris Carey | Wells Fargo | $182.00 | -0.3% |
| Nov 21, 2025 | Michael Lavery | Piper Sandler | $180.00 | -1.4% |
| Nov 3, 2025 | Andrew Lazar | Barclays | $188.00 | +2.9% |
| Oct 31, 2025 | David Palmer | Evercore ISI | $215.00 | +17.7% |
| Oct 31, 2025 | Megan Alexander Clapp | Morgan Stanley | $184.00 | +0.8% |
| Oct 31, 2025 | Matthew Smith | Stifel Nicolaus | $185.00 | +1.3% |
| Sep 16, 2025 | Leah Jordan | Goldman Sachs | $222.00 | +21.6% |
| Sep 9, 2025 | Michael Lavery | Piper Sandler | $167.00 | -8.6% |
| Nov 8, 2024 | Michael Lavery | Piper Sandler | $168.00 | -8.0% |
| Nov 7, 2024 | Matthew Smith | Stifel Nicolaus | $180.00 | -1.4% |
| Oct 23, 2024 | Michael Lavery | Piper Sandler | $165.00 | -9.7% |
| Oct 22, 2024 | Arun Sundaram | CFRA | $169.00 | -7.5% |
| Oct 22, 2024 | Bingqing Zhu | Redburn Partners | $165.00 | -9.7% |
Top Analysts Covering HSY
HSY vs Sector & Market
| Metric | HSY | Consumer Defensive Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.84 | 2.55 | 2.41 |
| Analyst Count | 25 | 12 | 18 |
| Target Upside | +22.9% | +1188.7% | +14.9% |
| P/E Ratio | 34.01 | -7.43 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $12.20B | $12.25B | $12.31B | 18 |
| 2027-03-31 | $3.04B | $3.13B | $3.18B | 5 |
| 2027-06-30 | $2.73B | $2.81B | $2.85B | 6 |
| 2027-09-30 | $3.32B | $3.41B | $3.46B | 9 |
| 2027-12-31 | $3.15B | $3.23B | $3.28B | 5 |
| 2028-03-31 | $3.17B | $3.25B | $3.30B | 4 |
| 2028-06-30 | $2.82B | $2.89B | $2.94B | 6 |
| 2028-09-30 | $3.40B | $3.49B | $3.55B | 9 |
| 2028-12-31 | $3.23B | $3.32B | $3.38B | 4 |
| 2029-12-31 | $13.08B | $13.19B | $13.34B | 9 |
| 2030-12-31 | $13.70B | $13.82B | $13.97B | 13 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $8.23 | $8.40 | $8.57 | 15 |
| 2027-03-31 | $2.51 | $2.60 | $2.65 | 5 |
| 2027-06-30 | $1.89 | $1.96 | $2.00 | 5 |
| 2027-09-30 | $2.67 | $2.76 | $2.82 | 5 |
| 2027-12-31 | $2.51 | $2.60 | $2.65 | 5 |
| 2028-03-31 | $2.66 | $2.76 | $2.82 | 6 |
| 2028-06-30 | $2.09 | $2.17 | $2.21 | 6 |
| 2028-09-30 | $2.77 | $2.87 | $2.93 | 7 |
| 2028-12-31 | $2.79 | $2.89 | $2.95 | 9 |
| 2029-12-31 | $11.18 | $11.30 | $11.47 | 6 |
| 2030-12-31 | $12.28 | $12.41 | $12.60 | 6 |
Frequently Asked Questions
What is the analyst consensus for HSY?
The consensus among 25 analysts covering The Hershey Company (HSY) is Hold with an average price target of $229.21.
What is the highest price target for HSY?
The highest price target for HSY is $250.00, set by Alexia Howard at Bernstein on 2026-02-06.
What is the lowest price target for HSY?
The lowest price target for HSY is $84.00, set by Alexia Howard at Bernstein on 2026-01-26.
How many analysts cover HSY?
25 analysts have issued ratings for The Hershey Company in the past 12 months.
Is HSY a buy or sell right now?
Based on 25 analyst ratings, HSY has a consensus rating of Hold (2.84/5) with a +22.9% upside to the consensus target of $229.21.
What are the earnings estimates for HSY?
Analysts estimate HSY will report EPS of $8.40 for the period ending 2026-12-31, with revenue estimated at $12.25B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.